Yonhap Infomax NewsSK Bioscience Co. has inaugurated its new Global R&PD Center in Songdo, Incheon, investing 377.2 billion won ($284 million) to enhance its premium vaccine portfolio and expand global development capabilities.
#YonhapInfomax #SKBioscience #VaccineDevelopment #SongdoRPD #PneumococcalVaccines #MRNAPlatform #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100454
#YonhapInfomax #SKBioscience #VaccineDevelopment #SongdoRPD #PneumococcalVaccines #MRNAPlatform #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100454
SK Bioscience Ushers in 'Songdo Era'—Strengthens Vaccine Development Capabilities
SK Bioscience Co. has inaugurated its new Global R&PD Center in Songdo, Incheon, investing 377.2 billion won ($284 million) to enhance its premium vaccine portfolio and expand global development capabilities.